The disclosure relates to a traditional Chinese medicine composition, comprising active ingredients derived from Cornu caprae or Cornu saigae tataricae, Radix scutellariae, Bulbus fritillariae ussuriensis, Radix glycyrrhizae, Radix et rhizoma rhei, Gypsum fibrosum, Calculus bovis artifactus and Lapis Chloriti, the said active ingredients comprise in parts by weight: at least 1600 parts of amino acids; at least 120 parts of gallic acid; at least 130 parts of liquiritin; at least 20 parts of liquiritigenin; at least 400 parts of baicalin; at least 40 parts of oroxyloside; at least 120 parts of wogonoside; at least 280 parts of glycyrrhizic acid; at least 12 parts of chrysin-7-O--D-glucoronic acid; at least 50 parts of aloe-emodin-8-O--D-glucopyranoside; at least 30 parts of chrysophanol-1-O--D-glucopyranoside; at least 45 parts of chrysophanol-8-O--D-glucopyranoside; at least 260 parts of hyodeoxycholic acid; at least 150 parts of cholic acid. The traditional Chinese medicine composition in the present invention possess antipyretic, anti-inflammatory and antitussive effects.

The disclosure relates to a traditional Chinese medicine composition, comprising active ingredients derived from Cornu caprae or Cornu saigae tataricae, Radix scutellariae, Bulbus fritillariae ussuriensis, Radix glycyrrhizae, Radix et rhizoma rhei, Gypsum fibrosum, Calculus bovis artifactus and Lapis Chloriti, the said active ingredients comprise in parts by weight: at least 1600 parts of amino acids; at least 120 parts of gallic acid; at least 130 parts of liquiritin; at least 20 parts of liquiritigenin; at least 400 parts of baicalin; at least 40 parts of oroxyloside; at least 120 parts of wogonoside; at least 280 parts of glycyrrhizic acid; at least 12 parts of chrysin-7-O--D-glucoronic acid; at least 50 parts of aloe-emodin-8-O--D-glucopyranoside; at least 30 parts of chrysophanol-1-O--D-glucopyranoside; at least 45 parts of chrysophanol-8-O--D-glucopyranoside; at least 260 parts of hyodeoxycholic acid; at least 150 parts of cholic acid. The traditional Chinese medicine composition in the present invention possess antipyretic, anti-inflammatory and antitussive effects.

A drug for treatment of breast cancer with antler and ginseng as sovereign drug and preparation method and application thereof are disclosed, where the drug is made of 12 parts of antler and 3 parts of ginseng as the sovereign drug, 10 parts of Angelicae sinensis radix and 10 parts of Radix paeoniae alba as the adjuvant drug, and combined with 5 parts of Radix bupleuri, 5 parts of Scutellariae radix, 10 parts of Cyperi rhizoma and 10 parts of thunberg fritillary bulb; the preparation method includes: step 1, soaking antler and ginseng separately; step 2, taking Angelicae sinensis radix, Radix paeoniae alba, Radix bupleuri, Scutellariae radix, Cyperi rhizoma and thunberg fritillary and adding water to fully immerse; step 3, decocting; step 4, filtering by gauze and combining filtrate for 3 times; and step 5, compressing to a paste, freezing and drying, and sealing and storing for future use.

A drug for treatment of breast cancer with antler and ginseng as sovereign drug and preparation method and application thereof are disclosed, where the drug is made of 12 parts of antler and 3 parts of ginseng as the sovereign drug, 10 parts of Angelicae sinensis radix and 10 parts of Radix paeoniae alba as the adjuvant drug, and combined with 5 parts of Radix bupleuri, 5 parts of Scutellariae radix, 10 parts of Cyperi rhizoma and 10 parts of thunberg fritillary bulb; the preparation method includes: step 1, soaking antler and ginseng separately; step 2, taking Angelicae sinensis radix, Radix paeoniae alba, Radix bupleuri, Scutellariae radix, Cyperi rhizoma and thunberg fritillary and adding water to fully immerse; step 3, decocting; step 4, filtering by gauze and combining filtrate for 3 times; and step 5, compressing to a paste, freezing and drying, and sealing and storing for future use.